Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
IM96 CAR-T cells
i
Other names:
IM96 CAR-T cells
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Beijing Imunopharm
Drug class:
GUCY2C-targeted CAR-T immunotherapy
Related drugs:
‹
GCC19CART (1)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
Mesothelin/GPC3/GUCY2C-CAR-T (0)
XKDCT080 (0)
GCC19CART (1)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
Mesothelin/GPC3/GUCY2C-CAR-T (0)
XKDCT080 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
GUCY2C expression
Colorectal Cancer
GUCY2C expression
Colorectal Cancer
IM96 CAR-T cells
Sensitive: C3 – Early Trials
IM96 CAR-T cells
Sensitive
:
C3
IM96 CAR-T cells
Sensitive: C3 – Early Trials
IM96 CAR-T cells
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login